Advertisement

Serum Markers for Diagnosis and Risk Stratification in Acute Coronary Syndromes

  • L. Kristin Newby
  • W. Brian Gibler
  • Robert H. Christenson
  • E. Magnus Ohman
Part of the Contemporary Cardiology book series (CONCARD)

Abstract

Both economic and clinical pressures increasingly necessitate accurate diagnosis and risk stratification of patients presenting to Emergency Departments (EDs) with suspected or actual acute coronary syndromes. Of the more than 6 million patients who present to EDs in the United States each year for evaluation of chest pain or anginal-equivalent symptoms, only about 15% are identified as having an acute myocardial infarction (MI). Conversely, the conventional evaluation, which includes a history, physical examination, screening electrocardiogram (ECG), and creatine kinase (CK)-MB assays, may miss up to 25% of acute MIs at presentation. When unstable angina and nonacute coronary artery disease presentations are accounted for, 40% of patients with chest pain do not have an underlying coronary etiology for their symptoms. The challenge is to identify both this group and the group at higher risk as early as possible, to promote rapid treatment of those who may benefit from specific medical or interventional approaches and to avoid costly hospitalization and testing in those at low risk.

Keywords

Chest Pain Acute Coronary Syndrome Acute Myocardial Infarction Cardiac Troponin Acute Coronary Syndrome Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Braunwald E, Mark DB, Jones RH, et al. Unstable angina: diagnosis and management. Clinical Practice Guideline No. 10, AHCPR Publication 94–0602. Agency of Health Care Policy and Research and the National Heart, Lung and Blood Institute, Rockville, MD, 1994.Google Scholar
  2. 2.
    McCarthy BD, Wong JB, Selker HP. Detecting acute cardiac ischemia in the Emergency Department: a review of the literature. J Gen Intern Med 1990; 5: 365–373.PubMedGoogle Scholar
  3. 3.
    Sawe U. Pain in acute myocardial infarction: a study of 137 patients in a coronary care unit. Acta Med Scand 1971; 190: 79–81.PubMedGoogle Scholar
  4. 4.
    Tierney WM, Fitzgerald J, McHenry R, et al. Physicians’ estimates of the probability of myocardial infarction in emergency room patients with chest pain. Med Decis Making 1986; 6: 12–17.PubMedGoogle Scholar
  5. 5.
    Lee TH, Cook FE, Weisberg M, et al. Acute chest pain in the emergency room: identification and examination of low risk patients. Arch Intern Med 1985; 145: 65–69.PubMedGoogle Scholar
  6. 6.
    Ingram DA, Fulton RA, Portal RW, P’ Aber C. Vomiting as a diagnostic aid in acute ischemic cardiac pain. BMJ 1980; 281: 636–637.PubMedGoogle Scholar
  7. 7.
    Uretsky BF, Farquhar DS, Berezin AF, et al. Symptomatic myocardial infarction without chest pain: prevalence and clinical course. Am J Cardiol 1977; 40: 498–503.PubMedGoogle Scholar
  8. 8.
    Villaneuva FS, Sabia PJ, Afrooktch A, et al. Value and limitations of current methods of evaluating patients presenting to the emergency room with cardiac-related symptoms for determining long-term prognosis. Am J Cardiol 1992; 69: 746–750.Google Scholar
  9. 9.
    Califf RM, Mark DB, Harrell FE, et al. Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease. J Am Coll Cardiol 1988; 11: 20–26.PubMedGoogle Scholar
  10. 10.
    Betriu A, Heras M, Cohen M, Fuster V. Unstable angina: outcome according to clinical presentation. J Am Coll Cardiol 1992; 19: 1659–1663.PubMedGoogle Scholar
  11. 11.
    Rude RE, Poole WK, Muller JE, et al. Electrocardiographic and clinical criteria for the recognition of acute myocardial infarction based on analysis of 3,697 patients. Am J Cardiol 1983; 52: 936–942.PubMedGoogle Scholar
  12. 12.
    Yusuf S, Pearson M, Sterry H, et al. The entry ECG in the early diagnosis and prognostic stratification of patients with suspected acute myocardial infarction. Eur Heart J 1984; 5: 690–696.PubMedGoogle Scholar
  13. 13.
    Califf RM, Ohman EM. The diagnosis of acute myocardial infarction. Chest 1992; 101: 106S–115S.PubMedGoogle Scholar
  14. 14.
    Granger C, Moffie I, for the GUSTO Investigators. Underuse of thrombolytic therapy in North America has been exaggerated: results of the GUSTO MI registry. Circulation 1994; 90 (Suppl I): 1–324 (abstract).Google Scholar
  15. 15.
    Karlson BW, Herlitz J, Petterson P, Hallgren P, Strombom U, Hjalmarson A. One-year prognosis in patients hospitalized with a history of unstable angina pectoris. Clin Cardiol 1993; 16: 397–402.PubMedGoogle Scholar
  16. 16.
    Califf RM, Mark DB, Harrell FE, et al. Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease. J Am Coll Cardiol 1988; 11: 20–6.PubMedGoogle Scholar
  17. 17.
    Selker HP, Griffith JL, D’Agostino RB. A tool for judging coronary care unit admission appropriateness, valid for both real-time and retrospective use. A time-insensitive predictive instrument (TIPI) for acute cardiac ischemia: a multicenter study. Med Care 1991; 29: 610–627.PubMedGoogle Scholar
  18. 18.
    Goldman L, Cook EF, Brand DA, et al. A computer protocol to predict myocardial infarction in emergency department patients with chest pain. N Engl J Med 1988; 318: 797–803.PubMedGoogle Scholar
  19. 19.
    Rouan GW, Lee TH, Cook EF, Brand DA, Weisberg MC, Goldman L. Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or nonspecific electrocardiograms. A report from the Multicenter Chest Pain Study. Am J Cardiol 1989; 64: 1087–1092.PubMedGoogle Scholar
  20. 20.
    Ohman EM, Armstrong PW, Christenson RH, et al., for the GUSTO-IIa Investigators. Cardiac troponin T for risk stratification in acute myocardial ischemia. N Engl J Med 1996; 335: 1333–1341.PubMedGoogle Scholar
  21. 21.
    Brush JE, Brand DA, Acampora D, et al. Use of the initial electrocardiogram to predict in-hospital complications of acute myocardial infarction. N Engl J Med 1985; 312: 1137–1141.PubMedGoogle Scholar
  22. 22.
    Savonitto S, Ardissino D, Ottani F, et al. Prognostic value of the admission electrocardiogram in acute coronary syndromes: results from the GUSTO-IIb trial. Eur Heart J 1997; 18 (Suppl): 124 (abstract).Google Scholar
  23. 23.
    Goldman L, Weinberg M, Weisberg M, et al. A computer-derived protocol to aid in the diagnosis of emergency room patients with acute chest pain. N Engl J Med 1982; 307: 588–596.PubMedGoogle Scholar
  24. 24.
    Schor S, Behar S, Modan B, Barell V, Drory J, Kariv I. Disposition of presumed coronary patients from an emergency room: a follow-up study. JAMA 1976; 236: 941–943.PubMedGoogle Scholar
  25. 25.
    Lee TH, Rouan GW, Weisberg MC, et al. Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency department. Am J Cardiol 1987; 60: 219–224.PubMedGoogle Scholar
  26. 26.
    Pozen MW, D’Agostino RB, Mitchell JB, et al. The usefulness of a predictive instrument to reduce inappropriate admissions to the coronary care unit. Ann Intern Med 1980; 92: 238–242.PubMedGoogle Scholar
  27. 27.
    Pozen MW, D’Agostino RB, Selker HP, et al. A predictive instrument to improve coronary care unit admission practices in acute ischemic heart disease: a prospective multicenter clinical trial. N Engl J Med 1984; 310: 1273–1278.PubMedGoogle Scholar
  28. 28.
    Gibler WB, Lewis LM, Erb RE, et al. Early detection of acute myocardial infarction in patients presenting with chest pain and non-diagnostic ECGs: serial CK-MB sampling in the emergency department. Ann Emerg Med 1990; 9: 1359–1366.Google Scholar
  29. 29.
    Gibler WB, Young GP, Hedges JR, et al., for the Emergency Medicine Cardiac Research Group. Acute myocardial infarction in chest pain patients with non-diagnostic ECGs: serial CK-MB sampling in the emergency department. Ann Emerg Med 1992; 21: 504–512.PubMedGoogle Scholar
  30. 30.
    The TIMI-IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q wave myocardial infarction: results of the TIMI-IIIB trial. Circulation 1994; 89: 1545–1556.Google Scholar
  31. 31.
    Rouan GW, Hedges JR, Toltzis R, Golstein-Wayne B, Brand D, Goldman L. A chest pain clinic to improve follow-up of patients released from an urban university teaching hospital emergency department. Ann Emerg Med 1987; 16: 1145–1150.PubMedGoogle Scholar
  32. 32.
    McCarthy BD, Behansky JR, D’Agostino RB, Selker HP. Missed diagnoses of acute myocardial infarction in the emergency department: results from a multicenter study. Ann Emerg Med 1993; 22: 579–582.PubMedGoogle Scholar
  33. 33.
    Puleo PR, Meyer D, Wathen C, et al. Use of a rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction. N Engl J Med 1994; 331: 562–608.Google Scholar
  34. 34.
    Rusnak RA, Stair TO, Hansen K, Fastow JS. Litigation against the emergency physician: common features in cases of missed myocardial infarction. Ann Emerg Med 1989; 18: 1029–1034.PubMedGoogle Scholar
  35. 35.
    Cardiology Preeminence Roundtable. Perfecting the Perfect MI Rule-out: Best Practices of Emergency Evaluation of Chest Pain. The Advisory Board Company, Washington, DC, 1994.Google Scholar
  36. 36.
    Hedges JR, Young GP, Henkel GF, et al. Serial ECGs are less accurate than serial CK-MB results for emergency department diagnosis of myocardial infarction. Ann Emerg Med 1992; 21: 1445–1450.PubMedGoogle Scholar
  37. 37.
    Gibier WB, Runyon JP, Levy RC, et al. A rapid diagnostic and treatment center for patients with chest pain in the emergency department. Ann Emerg Med 1995; 25: 1–8.Google Scholar
  38. 38.
    Gibier WB, Sayre MR, Levy RC, et al. Serial 12-lead electrocardiographic monitoring in patients presenting to the emergency department with chest pain. J Electrocardiol 1994; 26: 5238–243.Google Scholar
  39. 39.
    Selker HP, Zalenski RJ, Antman EM, et al. An evaluation of technologies for identifying acute cardiac ischemia in the Emergency Department: executive summary of a National Heart Attack Alert Program Working Group Report. Ann Emerg Med 1997; 29: 1–87.PubMedGoogle Scholar
  40. 40.
    Sabia P, Afrookteh A, Touchstone DA, et al. Value of regional wall motion abnormality in the emergency room diagnosis of acute myocardial infarction: a prospective study using two-dimensional echocardiography. Circulation 1991; 84: I85–I92.PubMedGoogle Scholar
  41. 41.
    Trippi JA, Lee KS, Kopp G, Nelson D, Kovacs R. Emergency echocardiography telemedicine: an efficient method to provide 24-hour consultative echocardiography. J Am Coll Cardiol 1996; 27: 1748–1752.PubMedGoogle Scholar
  42. 42.
    Levitt MA, Promes SB, Bullock S, Disano M, Young GP, Gee G, et al. Combined cardiac marker approach with adjunct two-dimensional echocardiography to diagnose acute myocardial infarction in the emergency department. Ann Emerg Med 1996; 27: 1–7.PubMedGoogle Scholar
  43. 43.
    Kontos MC, Jesse RL, Ornato JP, et al. Comparison between technetium-99m sestamibi imaging and troponin I for identifying patients with acute coronary syndromes. Circulation 1997; 96 (suppl I): I-333. (Abstract).Google Scholar
  44. 44.
    van Lente F, McErlean ES, DeLuca S, et al. Utility of a rapid bedside troponin T compared to quantitative troponin T in patients with suspected coronary syndromes. Circulation 1997; 96 (suppl I): I-215. (Abstract).Google Scholar
  45. 45.
    Hamm CW, Goldman BU, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing of cardiac troponin T or troponin I. N Engl J Med 1997; 337: 1648–1653.PubMedGoogle Scholar
  46. 46.
    Ohman EM, Armstrong PW, Weaver WD, et al. Prognostic value of whole-blood troponin T testing in patients with acute myocardial infarction in the GUSTO-III trial. Circulation 1997; 96 (suppl I): I-216. (Abstract).Google Scholar
  47. 47.
    Hoekstra JW, Hedges JR, Gibier WB, Rubison M, Christensen RA. Emergency Department CK-MB: a predictor of ischemic complications. Acad Emerg Med 1994; 1: 17–28.PubMedGoogle Scholar
  48. 48.
    Young GP, Green TR. The role of a single ECG, creatine kinase and CKMB in diagnosing patients with acute chest pain. Am J Emerg Med 1993; 11: 444–449.PubMedGoogle Scholar
  49. 48a.
    Newby LK, Christenson RH, Ohman EM. Role of troponin and other markers of myocardial necrosis. In: Topol EJ, ed. Acute Coronary Syndromes. New York: Marcel Dekker, 1998; pp. 405–535.Google Scholar
  50. 49.
    Downie AC, Frost PG, Fielden P, Joshi D, Dancy CM. Bedside measurement of creatine kinase to guide thrombolysis on the coronary care unit. Lancet 1993; 341: 452–454.PubMedGoogle Scholar
  51. 50.
    Parvin CA, Lo SF, Deuser SM, Weaver LG, Lewis LM, Scott MG. Impact of point-of-care testing on patients’ length of stay in a large emergency department. Clin Chem 1996; 42: 711–717.PubMedGoogle Scholar
  52. 51.
    Roxin LE, Culled I, Groth T, Hallgren T, Venge P. The value of serum myoglobin determinations in the early diagnosis of acute myocardial infarction. Acta Med Scand 1984; 215: 417–425.PubMedGoogle Scholar
  53. 52.
    Lindahl B, Venge P, Wallentin L (on behalf of the BIOMACS Study Group). Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring. Coron Artery Dis 1995; 6: 321–328.PubMedGoogle Scholar
  54. 53.
    Bais R, Edwards JB. Creatine kinase. Crit Rev Clin Lab Sci 1982; 16: 291–335.PubMedGoogle Scholar
  55. 54.
    Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s? Circulation 1993; 88: 750–763.PubMedGoogle Scholar
  56. 55.
    Anderson PAW, Malouf NN, Oakeley AE, Pagani ED, Allen PD. Troponin T isoform expression in humans. Circ Res 1991; 69: 1226–1233.PubMedGoogle Scholar
  57. 56.
    Saggin L, Gorza L, Ausoni S, Schiaffino S. Cardiac troponin T in developing, regenerating and denervated rat skeletal muscle. Development 1990; 110: 547–554.PubMedGoogle Scholar
  58. 57.
    Bodor GS, Survant L, Voss EM, Smith S, Porterfield D, Apple FS. Cardiac troponin T composition in normal and regenerating human skeletal muscle. Clin Chem 1997; 43: 476–484.PubMedGoogle Scholar
  59. 58.
    Mair J, Dienstl F, Puschendorf B. Cardiac troponin T in the diagnosis of myocardial injury. Crit Rev Clin Lab Sci 1992; 29: 31–57.PubMedGoogle Scholar
  60. 59.
    Adams JE III, Bodor GS, Davita-Roman VG, et al. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 1993; 88: 101–106.PubMedGoogle Scholar
  61. 60.
    Bodor GS, Porter S, Landt Y, Ladenson JH. Development of monoclonal antibodies for an assay of cardiac troponin I and preliminary results in suspected cases of myocardial infarction. Clin Chem 1992; 38: 2203–2214.PubMedGoogle Scholar
  62. 61.
    Wu AHB, Valdes R Jr, Apple FS, et al. Cardiac troponin T immunoassay for diagnosis of acute myocardial infarction. Clin Chem 1994; 40: 900–907.PubMedGoogle Scholar
  63. 62.
    Christenson RH, Duh SH, Newby LK, et al., for the GUSTO-IIa Investigators. Cardiac troponin T and cardiac troponin I: relative value in short-term risk stratification of patients with acute coronary syndromes. Clin Chem 1998; 44: 494–501.PubMedGoogle Scholar
  64. 63.
    Newby LK, Ohman EM, Granger CB, et al. Use of diagnostic tools in a chest pain unit: value of troponin T testing. J Am Coll Cardiol 1997; 29: 211A (abstract).Google Scholar
  65. 64.
    Wu AHB, Feng YJ, Contois JH, Pervaiz S. Comparison of myoglobin, creatine kinase-MB, and cardiac troponin I for diagnosis of acute myocardial infarction. J Clin Lab Sci 1996; 26: 291.Google Scholar
  66. 65.
    Bhayana V, Gougoulias T, Cohoe S, Henderson AR. Discordance between results for serum troponin T and troponin I in renal disease. Clin Chem 1995; 14: 312–317.Google Scholar
  67. 66.
    Li D, Keffer J, Corry K, et al. Nonspecific elevation of troponin T levels in patients with chronic renal failure. Clin Biochem 1995; 28: 474–477.PubMedGoogle Scholar
  68. 67.
    Frankel WL, Herold DA, Zeigler TW, Fitzgerald RL. Cardiac troponin T is elevated in asymptomatic patients with chronic renal failure. Am J Clin Pathol 1996; 106: 118–123.PubMedGoogle Scholar
  69. 68.
    Croitoru M, Taegtmeyer H. Spurious rises in troponin T in end-stage renal disease. Lancet 1995; 346: 974.PubMedGoogle Scholar
  70. 69.
    Hossein-Nia M, Nisbet J, Merton GK, Holt DW. Spurious rises of cardiac troponin T. Lancet 1995; 346: 1558.PubMedGoogle Scholar
  71. 70.
    Escalon JC, Wong SS. False-positive cardiac troponin T levels in chronic hemodialysis patients. Cardiology 1996; 87: 268–269.PubMedGoogle Scholar
  72. 71.
    Hafner G, Thome-Kromer B, Schaube J, et al. Cardiac troponins in serum in chronic renal failure. Clin Chem 1994; 40: 1790–1791.PubMedGoogle Scholar
  73. 72.
    Katus HA, Haller C, Muller-Bardorff M, et al. Cardiac troponin T in end-stage renal disease patients undergoing chronic maintenance hemodialysis. Clin Chem 1995; 41: 1201–1203.PubMedGoogle Scholar
  74. 73.
    Li D, Jailal I, Keffer J. Greater frequency of increased cardiac troponin T than cardiac troponin I in patients with chronic renal failure. Clin Chem 1996; 42: 114–115.PubMedGoogle Scholar
  75. 74.
    Braun SL, Baum H, Neumeier D, Vogt W. Troponin T and troponin I after coronary artery bypass grafting: discordant results in patients with renal failure. Clin Chem 1996; 42: 781–783.PubMedGoogle Scholar
  76. 75.
    Haller C, Zehelein J, Remppis A, et al. Cardiac troponin T in patients with renal failure. J Am Coll Cardiol 1997; 29: 234A (abstract).Google Scholar
  77. 76.
    Apple FS, Sharkey SW, Hoeft P, et al. Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: a 1-year outcomes analysis. Am J Kidney Dis 1997; 29: 399–403.PubMedGoogle Scholar
  78. 77.
    Sobel BE, Bresnehan GF, Shell WE, Yoder RD. Estimation of infarct size in man and its relation to prognosis. Circulation 1972; 46: 640–648.PubMedGoogle Scholar
  79. 78.
    Sobel BE, Roberts R, Larson KB. Estimation of infarct size from serum MB creatine phosphokinase activity: applications and limitations. Am J Cardiol 1976; 37: 474–485.PubMedGoogle Scholar
  80. 79.
    Thompson PL, Fletcher EE, Katavatis V. Enzymatic indices of myocardial necrosis, influence on short-and long-term prognosis after myocardial infarction. Circulation 1979; 59: 113–119.PubMedGoogle Scholar
  81. 80.
    Grande P, Hansen BF, Christianson C, Naestoft J. Estimation of acute myocardial infarct size in man by serum CK-MB measurements. Circulation 1982; 65: 756–764.PubMedGoogle Scholar
  82. 81.
    Christenson RH, O’Hanesian MA, Newby LK, et al, for the TAMI Study Group. Relation of area under the CK-MB release curve and clinical outcomes in myocardial infarction patients treated with thrombolytic therapy. Eur Heart J 1995; 16 (Suppl): 75 (abstract).Google Scholar
  83. 82.
    Baardman T, Hermens WT, Lenderink T, et al. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy. Eur Heart J 1996; 17: 237–246.PubMedGoogle Scholar
  84. 83.
    The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615–1622.Google Scholar
  85. 84.
    Simes RJ, Topol EJ, Holmes DR, et al., for the GUSTO-I Investigators Link between angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. Circulation 1995; 91: 1923–1928.PubMedGoogle Scholar
  86. 85.
    Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. Prognostic significance of admission troponin T concentrations in patients with myocardial infarction. Circulation 1996; 94: 1291–1297.PubMedGoogle Scholar
  87. 86.
    Lee KL, Woodlief LH, Topol EJ, et al., for the GUSTO-I Investigators. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. Circulation 1995; 91: 1659–1668.PubMedGoogle Scholar
  88. 87.
    Ohman EM, Armstrong PW, Weaver WD, et al. Prognostic value of whole-blood qualitative troponin T testing in patients with acute myocardial infarction in the GUSTO-III trial. Presented at the 70th Scientific Session of the American Heart Association, Orlando, FL, November 9–12, 1997.Google Scholar
  89. 88.
    Woodlief LH, Lee KL, Califf RM, for the GUSTO IIa Investigators. Validation of a mortality model in 1384 patients with acute myocardial infarction. Circulation 1995; 92 (Suppl I): I-776 (abstract).Google Scholar
  90. 89.
    Calvin JE, Klein LW, Van den Berg BJ, et al. Risk stratification in unstable angina: prospective validation of the Braunwald classification. JAMA 1995; 273: 136–141.PubMedGoogle Scholar
  91. 90.
    Lindahl B, Venge P, Wallentin L, for the FRISC Study Group. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996; 93: 1651–1657.Google Scholar
  92. 91.
    Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335: 1342–1349.PubMedGoogle Scholar
  93. 92.
    Christenson RH, Armstrong PW, O’Hanesian MA, et al., for the GUSTO-IIa Investigators. The value of serial troponin T measurement for risk stratification in patients with acute coronary syndromes. Circulation 1995; 92 (Suppl I): I-663 (abstract).Google Scholar
  94. 93.
    Newby LK, Christenson RH, Peck S, et al. Risk stratification by troponin T occurs within the first 30 days of acute coronary syndromes: one year results from the GUSTO-IIa troponin T substudy. Circulation 1997;96(Suppl I):I-215 (abstract.)Google Scholar
  95. 94.
    Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. Prospective study of the role of cardiac troponin T in patients admitted with unstable angina. BMJ 1996; 313: 262–264.PubMedGoogle Scholar
  96. 95.
    Lindahl B, Venge P, Wallentin L, for the Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. J Am Coll Cardiol 1997; 29: 43–48.PubMedGoogle Scholar
  97. 96.
    Hamm CW, Heeschen C, Goldmann BU, Barnathan E, Simoons ML, for the CAPTURE Investigators. Value of troponins in predicting therapeutic efficacy of abciximab in patients with unstable angina. J Am Coll Cardiol 1998; 31: 185A (abstract).Google Scholar
  98. 97.
    Luscher MS, Thygeson K, Ravkilde J, Heickendorff L. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. Circulation 1997; 96: 2578–2585.PubMedGoogle Scholar
  99. 98.
    Lee TH, Juarez G, Cook EF, et al. Ruling out acute myocardial infarction: a prospective multicenter validation of a 12-hour strategy for patients at low risk. N Engl J Med 1991; 324: 1239–1246.PubMedGoogle Scholar
  100. 99.
    Gaspoz JM, Lee TH, Cook EF, Weisberg MC, Goldman L. Outcomes of patients who were admitted to a new short stay unit to “rule-out” myocardial infarction. Am J Cardiol 1991; 68: 145–149.PubMedGoogle Scholar
  101. 100.
    Gomez MA, Anderson JL, Karagounis LA, Muhlestein JB, Moores FB, for the ROMIO Study Group. An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: results of a randomized study (ROMIO). J Am Coll Cardiol 1996; 28: 25–33.PubMedGoogle Scholar
  102. 101.
    Gaspoz JM, Lee TH, Weinstein MC, et al. Cost effectiveness of a new short-stay unit to “rule-out” myocardial infarction in low risk patients. J Am Coll Cardiol 1994; 24: 1249–1259.PubMedGoogle Scholar
  103. 102.
    Newby LK, Califf RM. Identifying patient risk: the basis for rational discharge planning after acute myocardial infarction. J Thromb Thrombol 1996; 3: 107–115.Google Scholar
  104. 103.
    Mikhail MG, Smith FA, Gray M, Britton C, Fredericksen SM. Cost-effectiveness of mandatory stress testing in Chest Pain Center patients. Ann Emerg Med 1997; 29: 88–98.PubMedGoogle Scholar
  105. 104.
    Roberts R, Fromm R, Beudreax A, et al. Multi-center blinded trial utilizing multiple diagnostic markers to exclude myocardial infarction in patients consecutively to the ER with chest pain. Circulation 1996; 94 (Suppl I): I-322 (abstract).Google Scholar
  106. 105.
    Kontos MC, Anderson FP, Hanbury CM, Roberts CS, Miller WG, Jesse RL. Use of the combination of myoglobin and CK-MB mass for the rapid diagnosis of acute myocardial infarction. Am J Emerg Med 1997; 15: 14–19.PubMedGoogle Scholar
  107. 106.
    Trahey TF, Dunevant SL, Thompson AB, et al. Early hospital discharge of chest pain patients using creatine kinase MB isoforms and stress testing-a community hospital experience. Circulation 1996; 94 (Suppl I): I-569 (abstract).Google Scholar
  108. 107.
    Wu AHB, Lane PL. Metaanalysis in clinical chemistry: validation of cardiac troponin T as a marker for ischemic heart diseases. Clin Chem 1995; 41: 1228–1233.PubMedGoogle Scholar
  109. 108.
    Newby LK, Ohman EM, Granger BB, et al. Use of diagnostic tools in a chest pain evaluation unit: value of troponin T testing. Presented at the 46th Scientific Session of the American College of Cardiology, Anaheim, CA, March 16–19, 1997.Google Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • L. Kristin Newby
  • W. Brian Gibler
  • Robert H. Christenson
  • E. Magnus Ohman

There are no affiliations available

Personalised recommendations